Caroline Demangel
4Patents
2h-index
18Co-inventors
41Inventor score
Filing activity: Apr 2, 2001 → Nov 16, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6559126B2 | Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof | Physics | 63 | Expired |
| US8747866B2 | Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti | Human Necessities | 5 | Active |
| US9598393B2 | Structural variants of mycolactones for use in modulating inflammation, immunity and pain | Chemistry; Metallurgy | 1 | Active |
| US7883712B2 | Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.